
XTL Biopharmaceuticals Ltd. XTLB
$ 1.43
-5.6%
Annual report 2022
added 12-21-2024
Country |
![]() |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. Shlomo Spokone Shalev |
Employees in the company |
- |
Shares |
- |
Market Cap[1] |
$ 442 M |
EBITDA (LTM) |
$ -520 K |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.